Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
11/11/1992 | EP0512087A1 Process for reactivating denatured protein. |
11/11/1992 | EP0512074A1 Molecules with antibody combining sites that catalyse hydrolysis reactions |
11/11/1992 | EP0512023A1 Medicaments and methods for treating aids and arc employing anti-carbohydrate antibodies and carbohydrate antigens |
11/11/1992 | EP0511978A1 Method of purifying recombinant polypeptides. |
11/11/1992 | EP0511970A1 Method for preparing an enzymatic hydrolyzate. |
11/11/1992 | EP0511964A1 METHOD FOR PREPARING A PROTEIN COMPRISING AT LEAST ONE INTRAMOLECULAR DISULPHIDE BOND BY OXIDATION, AT A pH OF LESS THAN 5.0, OF THE REDUCED RECOMBINANT PROTEIN. |
11/11/1992 | EP0511959A1 Method for recovering solubilized proteins |
11/11/1992 | EP0202300B1 Cdna clones coding for polypeptides exhibiting human granulocyte macrophage and eosinophil cellular growth factor activity |
11/11/1992 | CA2102800A1 Control of milk secretion |
11/10/1992 | WO1992019648A1 Wf11243 substance |
11/10/1992 | US5162504 Wich does not bind to non-prostatic antigens present in other tissues |
11/10/1992 | US5162503 Purification of interleukin-2 by receptor-affinity chromatography |
11/10/1992 | US5162498 Synthetic yeast leader peptides |
11/10/1992 | US5162227 Recombinant DNA vectors capable of expressing apoaequorin in E. coli |
11/10/1992 | US5162226 Therapeutic compositions against streptococcal infections, transformed hosts, methods of immunization and genetically engineered products |
11/10/1992 | US5162211 Process for producing a cyclic lipopeptide employing zalerion arboricola |
11/10/1992 | US5162208 Saccharomyces cerevisiae strain productive of a heterologous protein and process for preparing the said heterologous protein by fermentation of the said strain |
11/10/1992 | US5162207 Sucrose inducible expression vectors for bacillus sp. |
11/10/1992 | CA2102705A1 Wf11243 substance |
11/10/1992 | CA1309959C Parathryoid-specific radioimaging techniques |
11/07/1992 | WO1992019255A1 Gene manipulation and expression using genomic elements |
11/07/1992 | CA2102628A1 Gene manipulation and expression using genomic elements |
11/04/1992 | EP0511912A1 Yeast promoter and its use |
11/04/1992 | EP0511855A1 HBsAg escape mutant vaccine |
11/04/1992 | EP0511854A1 Multiple hepatitis B virus surface proteins which form particles |
11/04/1992 | EP0511747A1 Hybrid polypeptide containing an avidin binding polypeptide |
11/04/1992 | EP0511516A2 Schizosaccharomyces specific polypeptide |
11/04/1992 | EP0511311A1 Novel retroviral vectors |
11/04/1992 | EP0511300A1 Monoclonal antibody specific for non-immunodominant epitope of hiv proteins |
11/04/1992 | EP0511263A1 A platelet cell adhesion molecule and variants thereof |
11/04/1992 | EP0511221A1 Process for enriching or cleaning hirudin. |
11/04/1992 | EP0229782B1 Methods for identifying alleles associated with increased risk of diabetes |
11/04/1992 | CN1065867A Peptides and mixtures thereof for detecting antibodies to hepatitis c virus |
11/03/1992 | WO1992019265A1 Recombinant dna-derived cholera toxin subunit analogs |
11/03/1992 | CA2102105A1 Recombinant dna-derived cholera toxin subunit analogs |
11/03/1992 | CA2067598A1 Recombinant adn molecules coding for a receptor chain for the t-cell antigen, preparation process, antibody and drugs containing them |
11/03/1992 | CA1309681C Method and apparatus for enzymatic synthesis |
11/03/1992 | CA1309680C Airlift insect cell culture |
11/03/1992 | CA1309679C Serum free media for the growth of insect cells and expression of products thereby |
11/03/1992 | CA1309674C Signal peptide for the excretion of peptides in streptomycetes |
11/03/1992 | CA1309671C Monoclonal antibodies to cyclosporins |
11/03/1992 | CA1309670C Monoclonal antibodies to mucin-like human differentiation antigens |
10/31/1992 | WO1992019751A1 Yeast promoter and use thereof |
10/31/1992 | CA2108966A1 Yeast promoter and its use |
10/30/1992 | CA2067590A1 Multiple hepatitis b virus surface proteins which form particles |
10/30/1992 | CA2067405A1 Schizosaccharomyces-specific polypeptides |
10/30/1992 | CA2067290A1 Hepatitis b virus surface proteins with reduced host carbohydrate content |
10/30/1992 | CA2067003A1 Hbsag escape mutant vaccine |
10/29/1992 | WO1992018634A1 Plant promoter involved in controlling lipid biosynthesis in seeds |
10/29/1992 | WO1992018627A1 Glial mitogenic factors, their preparation and use |
10/29/1992 | WO1992018626A1 WATER-SOLUBLE POLYPEPTIDES HAVING HIGH AFFINITY FOR INTERFERONS α AND $g(b) |
10/29/1992 | WO1992018619A1 Heterodimeric receptor libraries using phagemids |
10/29/1992 | WO1992018534A1 Minimum recognition unit of a pem mucin tandem repeat specific monoclonal antibody |
10/29/1992 | WO1992018532A1 Rna, dna and virus antigen protein of non-a non-b hepatitis virus |
10/29/1992 | WO1992018530A1 SYNTHETIC CDw52(CAMPATH-1) PEPTIDE ANTIGEN |
10/29/1992 | WO1992018526A1 Production of phosphopeptides from casein |
10/29/1992 | WO1992018149A1 Assay systems for neurotrophin activity |
10/29/1992 | WO1992018140A1 Activity-dependent neurotrophic factor |
10/29/1992 | WO1992016623A3 Receptors for bombesin-like peptides |
10/29/1992 | WO1992011370A3 Polypeptides derived from proteins of the hepatitis c virus |
10/29/1992 | WO1992008985A3 Ligand-mediated immunofunctional hormone binding protein assay method |
10/29/1992 | DE4113385A1 Hybridtransposon mit pt-operon, plasmide und bakterienstaemme dafuer Hybrid transposon with pt-operon, plasmids and bakterienstaemme for it |
10/29/1992 | CA2585487A1 Water-soluble polypeptides with strong affinity for .alpha. and .beta. interferons |
10/29/1992 | CA2109100A1 Assay systems for neurotrophin activity |
10/28/1992 | EP0511116A1 Antigens recognized by polyarthrits rheumatoid antibodies, preparation and applications |
10/28/1992 | EP0511011A1 Novel antibodies and methods for their use |
10/28/1992 | EP0511003A1 Superactive GRF analogs |
10/28/1992 | EP0510902A1 Immunoassay for detecting group B streptococcus |
10/28/1992 | EP0510878A1 Human neurokinin-1 receptor |
10/28/1992 | EP0510773A1 Canine coronavirus subunit vaccine |
10/28/1992 | EP0510693A2 Expression of human serum albumin in pichia pastoris |
10/28/1992 | EP0510691A1 DNA coding for human cell surface antigen |
10/28/1992 | EP0510678A2 Expression of human serum albumin in pichia pastoris |
10/28/1992 | EP0510662A1 bFGF mutein and its production |
10/28/1992 | EP0510658A2 Improvement of the secretion yield of proteins with a disulfide bridge |
10/28/1992 | EP0510271A1 Novel R106 compounds |
10/28/1992 | EP0510082A1 Oxidized variants of gm-csf |
10/28/1992 | EP0510079A1 Proteins produced by human lymphocytes, dna sequence coding these proteins, and pharmaceutical and biological uses thereof |
10/28/1992 | EP0510075A1 Human receptor of tsh. sequence coding for such receptor |
10/28/1992 | EP0504291A4 Novel proteins with oncostatin m activity and process for their preparation |
10/28/1992 | EP0243485B1 Hybridoma tumor cell lines and their monoclonal antibodies to thaumatin |
10/28/1992 | CN1065729A Monoclonal antibodies |
10/28/1992 | CN1018793B Homologues of aprotinin produced from recombinant host, process, expression vector and recombinant host therefor and pharmaceutical use thereof |
10/27/1992 | WO1992019970A1 Methods to detect and treat diseases caused by bacterial allergens |
10/27/1992 | US5159064 Subjecting solution to pH of about 4 a temperature of at least 5 degrees delsius for at least 16 hours |
10/27/1992 | US5159062 Fusion polypeptides |
10/27/1992 | US5159059 Process for reduction of certain cyclohexapeptide compounds |
10/27/1992 | US5158886 Monoclonal antibodies specific for free N-acetylfuraminic acid and beta-glycosides and beta-glycoconjugates thereof |
10/27/1992 | US5158885 Mouse monoclonal antibodies raised to the t-cell line hsb-2 and t-cell chronic lymphocytic leukemia (t-cll) cells react with normal human t and b lymphocytes and monocytes |
10/27/1992 | US5158876 Process for the production of antibiotic R106 by a strain of Aureobasidium pullulans |
10/27/1992 | US5158875 Production of biologically active insulin-like growth factor i from high expression host cell systems |
10/27/1992 | CA2109088A1 Methods to detect and treat diseases caused by bacterial allergens |
10/27/1992 | CA2067304A1 Superactive grf analogs |
10/27/1992 | CA2066931A1 Bfgf mutein and its production |
10/21/1992 | EP0509831A1 Precursor form of bovine growth hormone releasing factor and related DNA compounds |
10/21/1992 | EP0509819A1 Monoclonal antibodies for measuring okadaic acid |
10/21/1992 | EP0509553A1 Anti-lymphotoxin antibody, its production and use |
10/21/1992 | EP0509056A1 Target-specific, cytotoxic, recombinant pseudomonas exotoxin |
10/21/1992 | EP0509006A1 Polypeptides selectively reactive with antibodies against human immunodeficiency virus and vaccines comprising the polypeptides |
10/21/1992 | EP0508983A1 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof |